# Determine the Effects of Gene Differences and Voriconazole on Enzyme CYP2B6 Activity in the Liver in Healthy Volunteers

> **NCT01104376** · NA · COMPLETED · sponsor: **Indiana University** · enrollment: 61 (actual)

## Conditions studied

- Efavirenz, Metabolism and Pharmacokinetics Changes

## Interventions

- **DRUG:** Efavirenz
- **DRUG:** voriconazole

## Key facts

- **NCT ID:** NCT01104376
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-04
- **Final completion:** 2013-04
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2014-12-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01104376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01104376, "Determine the Effects of Gene Differences and Voriconazole on Enzyme CYP2B6 Activity in the Liver in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01104376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*